SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018979
Filing Date
2018-08-03
Accepted
2018-08-02 18:23:22
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20180630.htm 10-Q 2023410
2 EX-10.1 rare-ex101_204.htm EX-10.1 35552
3 EX-10.2 rare-ex102_203.htm EX-10.2 18436
4 EX-10.3 rare-ex103_202.htm EX-10.3 44320
5 EX-31.1 rare-ex311_8.htm EX-31.1 17455
6 EX-31.2 rare-ex312_7.htm EX-31.2 17454
7 EX-32.1 rare-ex321_6.htm EX-32.1 10878
8 GRAPHIC gijl5vjoi14p000001.jpg GRAPHIC 63555
9 GRAPHIC gpat2x33fgxr000001.jpg GRAPHIC 47879
10 GRAPHIC gjvuzbrfshtr000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-18-018979.txt   6028232

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT rare-20180630.xml EX-101.INS 1161302
12 XBRL TAXONOMY EXTENSION SCHEMA rare-20180630.xsd EX-101.SCH 42338
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20180630_cal.xml EX-101.CAL 47409
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20180630_def.xml EX-101.DEF 102783
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20180630_lab.xml EX-101.LAB 260064
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20180630_pre.xml EX-101.PRE 204410
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 18989872
SIC: 2834 Pharmaceutical Preparations